Serum HER2 level measured by dot blot: a valid and inexpensive assay for monitoring breast cancer progression.
Human epidermal growth factor receptor 2 (HER2) is one of the most important prognostic and predictive factors for breast cancer patients. Recently, serum HER2 ECD level of patients detected by enzyme-linked immunoabsorbent assay (ELISA) has been shown to predict tumor HER2 status and reveal its ass...
Main Authors: | Li-Duan Tan, Yuan-Yuan Xu, Yue Yu, Xiao-Qing Li, Ying Chen, Yu-Mei Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3076436?pdf=render |
Similar Items
-
Development of a quick dot blot assay for the titering of bovine ephemeral fever virus
by: Li-Ting Cheng, et al.
Published: (2019-09-01) -
A dot-blot assay for the low density lipoprotein receptor.
by: F M Maggi, et al.
Published: (1986-05-01) -
Development of an assay platform for screening Src kinase inhibitors using dot-blot assay
by: Huang, Bo Yi, et al.
Published: (2016) -
Development of an Indirect ELISA and Dot-Blot Assay for Serological Detection of Rice Tungro Disease
by: Magdline Sia Henry Sum, et al.
Published: (2017-01-01) -
The development of a dot blot assay using gene probes for the detection of enteroviruses in water
by: Margolin, Aaron B.,1958-
Published: (1986)